The effect of pneumococcal immunization on total and antigen-specific B cells in patients with severe chronic kidney disease

BACKGROUND: While the 23-valent pneumococcal polysaccharide vaccine (PPV23) is routinely used in Canada and some other countries to prevent pneumococcal infection in adults with chronic kidney disease (CKD), patients develop a suboptimal antibody response to PPV23 due to their immune dysfunction. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaultier, Gabrielle Nicole, McCready, William, Ulanova, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849264/
https://www.ncbi.nlm.nih.gov/pubmed/31718534
http://dx.doi.org/10.1186/s12865-019-0325-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849264/
https://www.ncbi.nlm.nih.gov/pubmed/31718534
http://dx.doi.org/10.1186/s12865-019-0325-9

Ejemplares similares